推薦產品
product name
N-羟基马来酰亚胺, 97%
化驗
97%
形狀
solid
反應適用性
reaction type: Addition Reactions
mp
130-133 °C (dec.) (lit.)
應用
peptide synthesis
SMILES 字串
ON1C(=O)C=CC1=O
InChI
1S/C4H3NO3/c6-3-1-2-4(7)5(3)8/h1-2,8H
InChI 密鑰
BUXKULRFRATXSI-UHFFFAOYSA-N
尋找類似的產品? 前往 產品比較指南
一般說明
N-羟基马来酰亚胺(NHMI)是一种有机化合物,广泛用作有机合成的氧化剂。常用于将硫醇选择性氧化为二硫化物,也用于α,β-不饱和羰基化合物的合成。还可作为Michael受体,用于多肽和蛋白质的合成。
應用
N-羟基马来酰亚胺可作为氧化剂,原位生成N-羟基苯胺类物质,这种物质是N-取代苯胺和羟胺衍生物经由选择性偶联反应高效合成芳肟的重要中间体。
訊號詞
Danger
危險聲明
危險分類
Eye Dam. 1 - Skin Corr. 1B
儲存類別代碼
8A - Combustible corrosive hazardous materials
水污染物質分類(WGK)
WGK 3
閃點(°F)
Not applicable
閃點(°C)
Not applicable
個人防護裝備
Eyeshields, Faceshields, Gloves, type P3 (EN 143) respirator cartridges
分析證明 (COA)
輸入產品批次/批號來搜索 分析證明 (COA)。在產品’s標籤上找到批次和批號,寫有 ‘Lot’或‘Batch’.。
客戶也查看了
Molecules (Basel, Switzerland), 25(2) (2020-01-16)
The study of Diels-Alder reactions in materials science is of increasing interest. The main reason for that is the potential thermoreversibility of the reaction. Aiming to predict the behavior of a material modified with maleimido and furyl moieties, 1H NMR
Nanoscale, 10(33), 15865-15874 (2018-08-15)
The detection of mycotoxins in food is urgently needed because they pose a significant threat to public health. In this study, we developed a quantitative detection platform for mycotoxins by integrating multicolor upconversion nanoparticle barcode technology with fluorescence image processing
Nature communications, 7, 11064-11064 (2016-03-22)
There is a growing interest in sequence-controlled polymers toward advanced functional materials. However, control of side-chain order for vinyl polymers has been lacking feasibility in the field of polymer synthesis because of the inherent feature of chain-growth propagation. Here we
Journal of controlled release : official journal of the Controlled Release Society, 267, 119-132 (2017-04-17)
Biological drugs are exquisitely tailored components offering the advantages of high specificity and efficacy that are considered safe for treating diseases. Nevertheless, the effectiveness of biological drugs is limited by their inherent short biological half-life and poor stability in vivo.
Journal of controlled release : official journal of the Controlled Release Society, 324, 532-544 (2020-05-27)
Therapeutic proteins are attractive candidates for the treatment of human diseases. However, their short half-life often limits their clinical application. To overcome this problem, injectable hydrogels have been developed as depots for controlled release of therapeutic proteins, but these systems
我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.
聯絡技術服務